169 related articles for article (PubMed ID: 23026137)
1. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk.
Zhu Z; Gao X; He Y; Zhao H; Yu Q; Jiang D; Zhang P; Ma X; Huang H; Dong D; Wan J; Gu Z; Jiang X; Yu L; Gao Y
Cancer Res; 2012 Dec; 72(23):6163-72. PubMed ID: 23026137
[TBL] [Abstract][Full Text] [Related]
2. Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer.
Zhu J; Luo JZ; Li CB
Biochem Genet; 2019 Feb; 57(1):147-158. PubMed ID: 30073577
[TBL] [Abstract][Full Text] [Related]
3. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population.
Jiang Y; Chen S; Jia S; Zhu Z; Gao X; Dong D; Gao Y
DNA Cell Biol; 2011 Dec; 30(12):1027-32. PubMed ID: 21612396
[TBL] [Abstract][Full Text] [Related]
5. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
Xiong XD; Fang JH; Qiu FE; Zhao J; Cheng J; Yuan Y; Li SP; Zhuang SM
Mutat Res; 2008 Aug; 643(1-2):70-4. PubMed ID: 18640135
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
9. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis.
Yang F; Huo XS; Yuan SX; Zhang L; Zhou WP; Wang F; Sun SH
Mol Cell; 2013 Mar; 49(6):1083-96. PubMed ID: 23395002
[TBL] [Abstract][Full Text] [Related]
10. The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.
Hsu CM; Yang MD; Tsai CW; Ho CY; Chang WS; Chang SC; Jeng LB; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):671-7. PubMed ID: 23393366
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
[TBL] [Abstract][Full Text] [Related]
12. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
[TBL] [Abstract][Full Text] [Related]
13. Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.
Rahimi N; Azizi M; Bahari G; Narouie B; Hashemi M
Asian Pac J Cancer Prev; 2020 May; 21(5):1221-1226. PubMed ID: 32458625
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.
Bayram S
Gene; 2012 May; 498(2):264-9. PubMed ID: 22394463
[TBL] [Abstract][Full Text] [Related]
15. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
16. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
17. A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility.
Zhou C; Yu Q; Chen L; Wang J; Zheng S; Zhang J
Gene; 2012 Oct; 507(1):95-8. PubMed ID: 22824466
[TBL] [Abstract][Full Text] [Related]
18. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
19. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
[TBL] [Abstract][Full Text] [Related]
20. The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma.
Zhu X; Zhang J; Fan W; Wang F; Yao H; Wang Z; Hou S; Tian Y; Fu W; Xie D; Zhu W; Long J; Wu L; Zheng X; Kung H; Zhou K; Lin MC; Luo H; Li D
Carcinogenesis; 2013 Jun; 34(6):1273-80. PubMed ID: 23416888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
